Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

Trump Speaks in The Oval Office - Washington

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Howard Lutnick, US commerce secretary, stand behind US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

Trump Speaks in The Oval Office - Washington

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM